Omicinsight Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Buyout/LBO
- (In Progress)
- Investors
-
2
Omicinsight General Information
Description
Developer of a single-cell analysis platform designed to deliver molecular insights for biomedical research. The company's platform offers single-molecule sensitivity, resolution imaging, customizable analysis pipelines, and AI-driven data interpretation, enabling researchers, laboratories, and biotechnology organizations to uncover precise cellular insights and accelerate discoveries in medicine and life sciences.
Contact Information
Website
www.omicinsight.comCorporate Office
- 2255 Martin Avenue
- Suite D
- Santa Clara, CA 95050
- United States
Corporate Office
- 2255 Martin Avenue
- Suite D
- Santa Clara, CA 95050
- United States
Omicinsight Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Buyout/LBO | 18-Nov-2024 | In Progress | Generating Revenue | |||
| 2. Early Stage VC | 04-Feb-2026 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2024 | $54M | $54M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Omicinsight Patents
Omicinsight Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260318834-A1 | Digital pathology-based biomarker detection using fluorescent image analysis of chromogenic ihc stains | Pending | 13-Apr-2025 | ||
| WO-2026221981-A1 | Digital pathology-based biomarker detection using fluorescent image analysis of chromogenic ihc stains | Pending | 13-Apr-2025 | ||
| US-11366303-B2 | Method for detecting particles using structured illumination | Inactive | 30-Jan-2018 | ||
| US-11841495-B2 | Method for detecting particles using structured illumination | Active | 30-Jan-2018 | ||
| US-20190235222-A1 | Method for detecting particles using structured illumination | Active | 30-Jan-2018 | G02B21/367 |
Omicinsight Signals
Omicinsight Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Lifecore Partners | Venture Capital | Minority | ||
| Lotte Holdings (Japan) | Corporation | Minority |
Omicinsight FAQs
-
When was Omicinsight founded?
Omicinsight was founded in 2024.
-
Where is Omicinsight headquartered?
Omicinsight is headquartered in Santa Clara, CA.
-
What is the size of Omicinsight?
Omicinsight has 9 total employees.
-
What industry is Omicinsight in?
Omicinsight’s primary industry is Biotechnology.
-
Is Omicinsight a private or public company?
Omicinsight is a Private company.
-
What is Omicinsight’s current revenue?
The current revenue for Omicinsight is .
-
How much funding has Omicinsight raised over time?
Omicinsight has raised $54M.
-
Who are Omicinsight’s investors?
Lifecore Partners and Lotte Holdings (Japan) have invested in Omicinsight.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process